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Classical experiments by Osmond and Nossal (1) have demonstrated the continuous 
production of very high numbers of B lymphocytes in the bone marrow, but there are 
few indications that a  significant fraction of these ever migrates to the periphery and 
participates in the establishment of available repertoires. "Half-lives" of lymphocytes 
have been determined by labeling or killing dividing cells, but  these approaches do 
not resolve the question of whether the mitotic activity takes place among precursors 
that rapidly differentiate to competence and are exported to the periphery, or among 
mature, peripheral B  lymphocytes. These two alternatives have very different conse- 
quences for the stability of available repertoires, because the expansion of mature B 
cells will result in the exclusion of novel clones produced in the marrow. This question 
is fundamental,  because the size of the available antibody repertoire appears to be 
primarily limited by the numbers of different clones the individual contains at  any 
given time. We have now devised an approach that provides the direct measurement 
of the persistence of mature B  cells in the periphery, regardless of cell division. The 
results thus obtained indicate average decay rates of 50% per day for a  large fraction 
of normal spleen B  cells under quasi-physiologic conditions. 
Materials  and  Methods 
Mice.  Male C57BL/6  (B6),  C57BL/10.  Sc.Sn  (B10.Sn),  and  C57BL/10.Sc.Cr.  (B10.Cr) 
were obtained from our own colony, from Olac, Blackthorn, England, or from Bomholtgaard, 
Ry, Denmark, respectively. They were used between 2 and 5 mo of age. 
Cell Suspensions.  Spleen cells were prepared as described (2), and separated by size at unit 
gravity in continuous gradients of bovine serum albumin  (3).  Lymphocyte fractions with a 
sedimentation velocity of <4 mm/h were pooled and used as small cells. 
Cultures and Limiting Dilution Analysis.  These were done as previously described (2). In brief, 
limited numbers  of spleen cells were  distributed in  0.2-ml cultures containing 6  x  105  rat 
thymus filler cells in medium containing 5  X  10 -5 M  2-mercaptoethanol and  10%  fetal calf 
serum (FCS). For each determination of the frequency of reactive B cells, at least 6 different 
cell  concentrations  were  set  up,  with  48  replicate  identical  cultures  per  point.  Whenever 
indicated, the  cultures contained  optimal  concentrations  (50  ~g/ml)  of lipupolysaccharide 
(LPS) from Salmonella abortus equi (Difco Laboratories, St. Louis, Mo.). All cultures were assayed 
on  day 5  for  IgM-secreting plaque-forming cells (PFC),  in  the  protein A-plaque assay  (4). 
Cultures containing >10 PFC were scored as positive, and the results were shown to conform 
to the first-order term of Poisson's distribution. The frequencies of reactive cells shown were 
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derived from semi-log plots, and indicate the numbers of cells per culture allowing 63% of the 
cultures to respond. 
Cell Transfers.  The small cell  fraction purified from spleen  cells was washed in balanced 
saline solution,  adjusted to 50 ×  106 cells/ml and injected intravenously into recipient mice. 
Splenic Localization of Transferred Cells.  Spleen cells were labeled with 51Cr after removal of 
erythrocytes and dead cells as described in detail (5). They were then transferred intravenously 
into normal mice and, 24 h  later the recipients were killed  and the amount of radioactivity 
recovered in  the  spleen  was  measured  and  expressed  as  a  percentage of the  total  cellular 
radioactivity injected. 
Results and  Discussion 
The mouse strain C57BL/10Sc.Cr (B 10.Cr) was previously found to carry a mutant 
gene at the lps locus in chromosome 4 (6) controlling the expression ofa B cell receptor 
for LPS from gram-negative bacteria, which can be serologically (7) and functionally 
(2)  identified in roughly one-third of all splenic B cells. B lymphocytes of this strain 
fail to recognize LPS as a polyclonal mitogen. The mutation must have occurred after 
this  substrain  was separated  from the  related  C57BL/10Sc.Sn  (B10.Sn)  strain  that 
shows full reactivity to this mitogen (8). No other differences between these strains are 
known, and they are fully histocompatible. All attempts to induce mutual serological 
or cellular immunity by grafting of cells or tissues in various immunization protocols 
have failed thus far (A. Coutinho, unpublished results). The same applies to another 
related strain, C57BL/6. 
The  strategy  in  these  experiments  was  to  follow  the  decay of LPS-responder  B 
lymphocytes in histocompatible, untreated LPS-nonresponder recipients, using tech- 
niques  that  provide the  direct  count,  by limiting dilution  analysis, of all  mitogen- 
reactive cells in a population (2).  Because the spleen is the major site of migration for 
B lymphocytes newly formed in the marrow (1), we were concerned,  in the present 
observations, with  the  turnover  of splenic  B  cells.  To  minimize  extraneous  effects 
caused by differential homing patterns of lymphocyte populations, we have followed 
LPS-responder spleen cells in the recipient's spleen.  Table I  shows the limits of the 
method, namely the frequencies of splenic B cells from B10.Cr and B10.Sn that can 
be activated by LPS to grow as clones of IgM-secreting PFC, as well as those measured 
in the absence of LPS. The latter are probably stimulated by FCS components, and 
their  frequencies  are  comparable  in  both  strains  of mice and  to  that  obtained  in 
B 10.Cr mice in the presence of LPS (1:6,000 spleen cells), whereas in LPS-responders, 
1:5 spleen cells is detected as an LPS-reactive clonal precursor. As also shown in Table 
I, in vitro mixtures of LPS-responder and nonresponder spleen cells, when analyzed 
for  the  frequency  of LPS-reactive  clones,  provide  the  correct  count;  that  is,  the 
frequency expected from the independent  measurements in each cell population. 
To avoid stem-cell contamination in the spleen cell populations to be transferred, 
small lymphocytes were purified  (3)  and used in the transfers.  It is well known that 
viable lymphocytes, after intravenous transfer, follow specific patterns of traffic and 
homing  (5).  By  24  h,  the  distribution  of injected  lymphocytes is  thought  to  have 
stabilized  and we therefore took this  time as the starting point  in our experiments. 
Two independent  measurements of the numbers of transferred cells homing to the 
spleen were taken at 24 h. One involved the conventional technique of labeling the 
transferred  cells  with  radioactive  chromium  and  determining  the  fraction  of the 
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TABLE  I 
Frequency of LPS-reactive Cells in the Spleen of LPS-responder and LPS- 
nonresponder Strains of Mice 
LPS  Without LPS 
Experiment I 
B  10.Sn  1:5  1:5,500 
B  10.Cr  1:6,000  1:6,000 
Experiment 2 
B6  1:12  ND:I: 
B6 + B10.Gr* 
expected  1  : 108  ND 
observed  1:100  ND 
B  10.Cr  1:5,500  ND 
* In mixing experiments, spleen cells from LPS-responder mice were diluted 
1:9 with cells from LPS-nonresponder mice. 
:~ Not determined. 
(5),  the  results  shown  in  Table II demonstrate  that  ~20%  of the  injected  cells are 
present  in the spleen 24 h  after transfer.  Radioactivity measurements at these early 
times reflect viable cell counts as shown by determining the numbers of LPS-reactive 
(donor)  B cells present in the recipient spleen at the same time. Table II also shows 
that 20% of the injected cells can be recovered. 
The  removal of cells  from  the  donor  spleen  and  their  purification  and  transfer 
certainly  result  in  damage  that  influences  the  survival  in  the  host.  Therefore,  the 
numbers of donor cells persisting in the host cannot be compared to the total number 
transferred. However, this difficulty is obviated if the numbers of donor cells found in 
the recipient spleen at 24 h  are taken as the starting value in the experiment. 
Thus, injured or dead cells do not circulate and are rapidly retained in nonlymphoid 
organs, primarily the liver (5). That is, the 24-h value represents the total numbers of 
cells that were successfully transferred and that will follow "normal" rates of decay in 
the host. This measure also corrects for the possibility that transferred cells home to 
organs other than spleen, as these are then excluded from the experiment. Frequency 
determinations of LPS-reactive cells in the recipient spleen were then performed in 
the  days  after transfer.  These  frequencies  allowed  for  the  calculation  of the  total 
numbers  of LPS-reactive  cells  in  the  organ,  and  these  were  compared  with  the 
numbers  found  24  h  after  transfer.  Taking  the  fraction  recovered  at  24  h  as  the 
starting  (100%)  value,  the logarithmic plot  of the  decay with  time of LPS-reactive 
cells in  the recipient  spleen  is shown  in  Fig.  1.  These results were obtained  in  two 
independent  experiments defining precisely the same curve, namely a  decay rate of 
50%  per  day.  After  day  5  of transfer,  these  methods  become  unsuitable,  as  the 
"background" frequencies in  B10.Cr  make it difficult  or impossible to detect  small 
numbers of cells. 
The interpretation of these results must consider first the possibility that the rapid 
decay rate observed  represents  active elimination  of donor  cells  in  nonphysiologic 
conditions,  rather than  the  normal  dynamics  in  the system. This appears unlikely, 
however, as no histocompatibility reactions could  be detected  in  this strain combi- 
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TABLE II 
Number of Lymphocytes  from LPS-responder Mice Recovered in the Spleen 24 h after Transfer into LPS- 
nonresponder Mice* 
Percent of the trans-  Percent of injected  Frequency of LPS-reac-  Total number of LPS-  ferred LPS-reactive  51Cr-labeled  cells re- 
tive cells in recipient's  reactive cells recovered in  cells in recipient's  covered in recipient's 
spleen  recipient's spleen  spleen:~  spleen 
1:400  158,000  19,8  21.2 
* All results are averages of three to five recipient mice. 
:~ The frequency of LPS-reactive cells in the recipient's spleen was determined by limiting  dilution analysis, 
and the number of LPS-reactive  ceils recovered  is expressed  as a  percentage  of the number of LPS- 
reactive cells injected, as assessed by limiting dilution analysis on the population of injected cells. 
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FIG.  1.  Small spleen lymphocytes  from LPS-responder  mice were transferred intravenously into 
LPS-nonresponder mice.  At  the  indicated times after  transfer,  recipients were  killed  and  the 
frequencies of LPS-reactive  B lymphocytes  in spleen cells were determined. The total numbers of 
LPS-reactive cells remaining in the recipient spleen at the different time-points were then calculated 
as a fraction of the number of LPS-reactive cells found at 24 h after transfer. The figure shows the 
results obtained in two independent experiments. 
possibility, identical experiments were  performed  using either  normal  recipients  or 
B10.Cr  mice that  had  been "immunized"  3  mo earlier with  107 B6 spleen cells, the 
donor inoculum used in these experiments.  Results shown in Table  III demonstrate 
that both the homing to the host spleen and the decay in the organ of LPS-reactive 
donor B  cells are not affected by previous immunization of the recipients, making it 
very  unlikely that  the  decay  rates  observed  are  the  result  of active  elimination by 
immune mechanisms. Furthermore, the transfer of<5  ×  106 B ceils represents a  minor 
fraction of the total  numbers produced  daily in the  normal system  and  therefore  it 
should not be expected to introduce gross alterations in the physiologic turnover rates. 
The experimental approach  described here provides conditions that are very little, if 
at all, immunogenic in contrast to previously used markers, e.g., allotypic. In addition, 998  DE  FREITAS AND COUTINHO  BRIEF DEFINITIVE REPORT 
TABLE III 
Recovery of LPS-responder Lymphocytes  from the Spleens of Normal or Immunized LPS-nonresponder Hosts 
Percent of  Donor cells persist-  transferred LPS- 
Frequency of LPS-  reactive cells in  ing in spleen as a  Day of assay  State of recipient  reactive cells  fraction of 24 h 
recipients spleen  value 
at 24 h 
1  Normal  1:140  0.29  -- 
Immune  1  : 125  0,3 t  -- 
4  Normal  1  : 1,400  --  0.1 
Immune  1  : 1,300  --  0.096 
Normal  BI0.Cr mice, or mice given one intravenous  injection of l0  T spleen cells from  B6 mice 3 mo 
previously, were used as recipients of B6 spleen cells, as described in the text.  1 and 4 d after transfer, 
spleen  ceils from  groups  of three  mice  were  pooled  and  the  frequencies  of LPS-reactive  cells were 
determined,  as in Table I. Fractions of donor cells homing to the spleen at 24 h were determined as in 
Table II, and those of the persisting cells were determined as in Fig. 1. 
our assay requires reactivity and functional performance of the transferred cells, thus 
excluding those still alive but  already unreactive to competent  stimuli that  can  be 
detected  in  other  protocols.  Finally,  the  responses  are  studied  in  vitro,  and  the 
functional performance is therefore not influenced by regulatory mechanisms or other 
conditions specific to the host environment. 
It might be argued that the B  cell population defined by reactivity to LPS is not a 
representative sample of the whole B  cell compartment.  It may well be that  donor 
LPS-reactive cells in our experiments did not in fact decay in the recipient spleen, but 
simply differentiated to other stages along the pathways of B  cell development with 
a  concomitant  loss  of LPS-reactivity. Alternatively, LPS-reactive cells could  have 
migrated  out  of the spleen to,  for example,  lymph  nodes.  In  these cases, however, 
similar decay rates would apply for all stages in a  given differentiative line or for the 
cells  in  the  next  lymphoid  organ,  as  the  B  cell  compartment  is  kept  reasonably 
constant in the physiologic steady state. 
It can  be postulated,  however,  that  LPS-reactive lymphocytes compose an  inde- 
pendent subset that is distinct in rate of decay from the other two-thirds of splenic B 
ceils. This possibility cannot be excluded, although it would appear unlikely, because 
we have previously found that LPS-reactive cells compare well with the rest of the B 
lymphocyte compartment  in the rates of decay and recovery, after in vivo killing of 
cells in S-phase with hydroxyurea (A. A. Freitas, B. Rocha, L. Forni and A. Coutinho, 
manuscript submitted for publication). 
The present results concern at least one-third of all splenic B cells. If they are taken 
as representative of the majority of B  lymphocytes in the spleen, it would follow that 
~25  ×  106  B  cells  would  leave  the  organ  (or  die)  in  a  day.  These  numbers  are 
comparable  to  those  determined  by Osmond  and  Nassal  (1)  for  the  rate  of B  cell 
production in bone marrow, and these observations would therefore suggest that the 
majority of newly  formed  B  cells migrate  to  the  periphery  and  participate in  the 
astonishingly high  turnover rate described here.  It should  be pointed out, however, 
that  although  these very high  decay rates could apply to the majority of splenic B 
cells, other B  lymphocyte subsets  might  have  considerably longer life spans.  These 
differences may result  from  regulatory mechanisms  operating at  the periphery and 
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marrow.  This  view  might  explain  the  wide  discrepancies  in  the  life  span  of B 
lymphocytes previously determined,  which vary from 2 d  to 7 wk, according to the 
experimental  system and the clonal specificity analyzed (8-10). 
Summary 
To determine the persistence of immunocompetent B lymphocytes at the periphery, 
regardless  of cell  division, we have followed the decay of lipopolysaccharide  (LPS)- 
reactive  B  cells  in  LPS-nonresponder,  histocompatible  hosts.  Both  the  numbers  of 
transferred  cells  and  of those persisting  in  the  recipients  could  be  determined  with 
precision by limiting dilution analysis of the various cell populations.  Decay rates of 
50%  per  day  were  determined.  Because  we  could  exclude  immune  elimination  of 
donor  cells  and  the  numbers  of transferred  cells  were  too  low  to  result  in  gross 
alterations  of the physiologic turnover rates,  we conclude that  the majority of LPS- 
reactive B lymphocytes and a  large part of the whole B cell compartment show this 
astonishingly high rate of decay. 
The method introduced here might prove useful in a  variety of clonal assays, as it 
can detect cells present at a  very low frequency. 
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